Centrosome Linker–Induced Tetraploid Segregation Errors Link
Total Page:16
File Type:pdf, Size:1020Kb
Published OnlineFirst May 21, 2018; DOI: 10.1158/1541-7786.MCR-18-0062 Oncogenes and Tumor Suppressors Molecular Cancer Research Centrosome Linker–induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers Andrea Remo1, Erminia Manfrin2, Pietro Parcesepe2, Alberto Ferrarini3, Hye Seung Han4, Ugnius Mickys5, Carmelo Laudanna6, Michele Simbolo2, Donatella Malanga6, Duarte Mendes Oliveira6, Elisabetta Baritono1, Tommaso Colangelo7, Lina Sabatino8, Jacopo Giuliani1, Enrico Molinari1, Marianna Garonzi9, Luciano Xumerle9, Massimo Delledonne9,10, Guido Giordano11,12, Claudio Ghimenton2, Fortunato Lonardo13, Fulvio D'angelo14, Federica Grillo15, Luca Mastracci15, Giuseppe Viglietto6, Michele Ceccarelli8,14, Vittorio Colantuoni8, Aldo Scarpa2,16, and Massimo Pancione8,17 Abstract Centrosome anomalies contribute to tumorigenesis, but it metastatic model harboring 1p36.13 deletion results in cor- remains unclear how they are generated in lethal cancer rection of centrosome segregation errors and cell death, reveal- phenotypes. Here, it is demonstrated that human microsatel- ing a mechanism of tolerance to mitotic errors and tetraploi- lite instable (MSI) and BRAFV600E-mutant colorectal cancers dization promoted by deleterious 1p36.13 loss. Accordingly, with a lethal rhabdoid phenotype are characterized by inac- cancer cells lacking 1p36.13 display far greater sensitivity to tivation of centrosomal functions. A splice site mutation that centrosome spindle pole stabilizing agents in vitro. These data causes an unbalanced dosage of rootletin (CROCC), a cen- shed light on a previously unknown link between centrosome trosome linker component required for centrosome cohesion cohesion defects and lethal cancer phenotypes providing new and separation at the chromosome 1p36.13 locus, resulted in insight into pathways underlying genome instability. abnormally shaped centrosomes in rhabdoid cells from human colon tissues. Notably, deleterious deletions at Implications: Mis-segregation of chromosomes is a prom- 1p36.13 were recurrent in a subgroup of BRAFV600E-mutant inent feature of chromosome instability and intratumoral and microsatellite stable (MSS) rhabdoid colorectal cancers, heterogeneity recurrent in metastatic tumors for which the but not in classical colorectal cancer or pediatric rhabdoid molecular basis is unknown. This study provides insight tumors. Interfering with CROCC expression in near-diploid into the mechanism by which defects in rootletin, a cen- BRAFV600E-mutant/MSI colon cancer cells disrupts bipolar trosome linker component causes tetraploid segregation mitotic spindle architecture, promotes tetraploid segregation errors and phenotypic transition to a clinically devastating errors, resulting in a highly aggressive rhabdoid-like pheno- form of malignant rhabdoid tumor. Mol Cancer Res; 1–11. type in vitro. Restoring near-wild-type levels of CROCC in a Ó2018 AACR. 1Pathology Unit, "Mater Salutis" Hospital AULSS9, Legnago (Verona), Italy. Research on Cancer, University and Hospital Trust of Verona, Verona, Italy. 2Department of Diagnostics and Public Health, Section of Pathology, University 17Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, and Hospital Trust of Verona, Verona, Italy. 3Menarini Silicon Biosystems S.p.A, Complutense University, Madrid, Spain. Bologna, Italy. 4Department of Pathology, Konkuk University School of Medicine, Seoul, Korea. 5National Center of Pathology, Affiliate of Vilnius Note: Supplementary data for this article are available at Molecular Cancer University Hospital Santariskiu Clinics, Vilnius, Lithuania. 6Department of Research Online (http://mcr.aacrjournals.org/). Experimental and Clinical Medicine "Gaetano Salvatore", University "Magna Grecia", Catanzaro, Italy. 7Institute for Stem Cell Biology, Regenerative Medicine A. Remo, E. Manfrin, and P. Parcesepe contributed equally to this article. and Innovative Therapies (ISBReMIT), Casa Sollievo della Sofferenza-IRCCS, San Giovanni Rotondo, Italy. 8Department of Sciences and Technologies, University Corresponding Authors: Massimo Pancione, Department of Sciences and of Sannio, Benevento, Italy. 9Functional Genomics Center, Department of Technologies, University of Sannio, Via Port'Arsa, 1182100 Benevento, Italy. Biotechnology, University of Verona, Verona, Italy. 10Personal Genomics S.r.l., Phone: 3908-2430-5157; Fax: 3908-2430-5147; E-mail: Verona, Italy. 11CRO Aviano National Cancer Center, Aviano, Italy. 12Medical [email protected]; Aldo Scarpa, ARC-NET Research Centre, Oncology Unit, San Filippo Neri Hospital, Rome, Italy. 13Medical Cytogenetics Policlinico GB Rossi, Piazzale L.A. Scuro, Verona, Italy. Phone: 3904-5812- and Molecular Genetics Unit, AORN "Gaetano Rummo," Benevento, Italy. 4043; Fax: 3904-5812-7432; E-mail: [email protected] 14 Bioinformatics Laboratory, BIOGEM scrl, Ariano Irpino, Avellino, Italy. doi: 10.1158/1541-7786.MCR-18-0062 15Department of Surgical and Diagnostic Sciences (DISC), University of Genova and S. Martino Polyclinic Hospital, Genova, Italy. 16ARC-Net Centre for Applied Ó2018 American Association for Cancer Research. www.aacrjournals.org OF1 Downloaded from mcr.aacrjournals.org on September 26, 2021. © 2018 American Association for Cancer Research. Published OnlineFirst May 21, 2018; DOI: 10.1158/1541-7786.MCR-18-0062 Remo et al. Introduction from ATCC. BJ human fibroblasts and G401 cells derived from normal foreskin and pediatric rhabdoid tumor were used as a The century-old hypothesis on the relationship between cen- nonneoplastic control and a pure rhabdoid model, respectively. trosomes and cancer, formulated by the German embryologist Theodor Boveri more than 100 years ago (1, 2), remains unan- Whole-exome sequencing swered. Centrosome abnormalities, consisting usually in increased Whole-exome sequencing with 100-bp paired reads was per- numbers, are common in human tumors (3), and experimentally formed with a HiSEQ1000 (Illumina), using 1.3 mg genomic induced tetraploid cells from extra centrosomes can be critical DNA (based on fluorometric Picogreen dsDNA quantification), for aneuploidy and metastatic progression of malignancy (3, 4). and enrichment for whole exome was done according to TruSeq fi However, insuf cient progress has been made in our knowledge Exome Enrichment Guide (Illumina). on genetic defects underlying centrosome anomalies in tumori- genesis (1–4). In this scenario, the rare and lethal pathologic Functional in vitro assays variant of common colorectal cancers showing rhabdoid pheno- RKO cells were transiently transfected with SureSilencing con- type (5–7), is of particular interest as it features recurrent mitotic trol or CROCC shRNA expression plasmids KH23140P (Qiagen) anomalies of enigmatic origin (8–10). We thus hypothesized that containing the puromycin-resistant cassette. After selection puro- the systematic study of rare rhabdoid colorectal cancers, could mycin (Thermo Fisher Scientific), single colonies were amplified provide insights into biological mechanisms responsible for the and assessed for efficient CROCC silencing by qPCR and Western generation of genome instability and reveal key factors for the blot analysis, respectively. HT29 and T84 cells were transfected development of aggressive disease entities. To test this idea, we with the full-length CROCC coding sequence or a truncated form performed whole-exome sequencing of two rhabdoid colorectal (1–494 aa) cloned with GFP epitope or GFP alone (used as þ cancers and discovered an enrichment of centrosome anomalies control). For long-term experiments, CROCC-GFP cells were and inactivation of Rootletin encoded by ciliary rootlet coiled-coil maintained in 0.6 mg/mL of G418. (CROCC) gene (11, 12), a structural component of the centro- some linker, which assembles and keeps the two centrioles con- Statistical analysis nected. Centrosomal alterations were assessed in an expanded Data are presented as mean, medians, and ranges. P values of series of rare rhabdoid colorectal cancers and related tumors, and <0.05 (two tailed) were considered to be significant. Statistical functionally characterized in colorectal cancer cellular models. analyses were conducted by GeneSpring R/bioconductor v.12.5 and R based package, SPSS v15, and GraphPad Prism 5. Materials and Methods Materials and Methods and any associated references as a Results continuation of the main text are described more in detail within Discovery of CROCC mutations and centrosome anomalies the Supplementary Material. Two previously reported primary BRAFV600E-mutant rhabdoid colorectal cancers (RC1 and RC2; refs. 9, 10), harboring MSI due Patient and tissue cohort to defective DNA mismatch repair (MMR) machinery caused by This study was conducted in accordance with Declaration of promoter methylation of the MLH1 gene, were subjected to Helsinki ethical guidelines. It was approved by an institutional whole-exome sequencing (WES) using DNA from FFPE-matched review board, approval no. 997CESC from the Ethics Commit- tumor/normal samples (Supplementary Table S1). We detected tee (Comitato Etico di Verona e Rovigo dell'Azienda Ospeda- an exceptionally large number of somatic point mutations, 1,056 liera Universitaria Integrata) on September 7, 2016, documen- and 1,078 per 106 bases for RC1 and RC2, respectively, which is ted by the CESC prot. 42160 on 9 September 2016, and consistent with the presence of MMR defects (13–15; Fig. 1A). formalized by the General Manager with deliberation no. About twenty percent